The woman, from Essex, received the six figure sum after she became addicted to the video puzzle game when she was prescribed ...
Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.
Dopamine rushes, withdrawals, and detoxes are trending among wellness gurus online. But experts say the science behind the ...
It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...
Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...
“In the brain, GLP-1 receptors act like a stop light and tell certain areas of the brain to stop releasing dopamine ... who took a GLP-1 receptor agonist medication were less likely to be ...
Dopamine agonists are the first-line treatment for RLS; their efficacy has mainly been demonstrated by short-term trials of oral medications. Oertel and colleagues (2011) aimed to determine the ...